Vaccines
New Findings from University of Minnesota Describe Advances in Vaccines
Published in Vaccine Weekly, July 13th, 2011
2011 JUL 13 -- According to the authors of recent research published in the journal Biotechnology Progress, "Dendritic cells (DCs) are considered the most efficient antigen-presenting cells and are therefore ideal targets for in vivo delivery of antigen for vaccines. We are investigating the strategy of using CD40 ligand (CD40L) as a targeting moiety because this protein has the potential to not only target DCs, but also stimulate cell maturation, leading to more potent immune responses."
"We have shown that a recombinant, monomeric CD40 ligand fusion protein conjugated to polystyrene micro- and nanoparticles led to significantly enhanced uptake by...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2011-07-13)
More Articles from Vaccine Weekly
- Heart Attack
New Findings in Heart Attack Described by T.J. Marrie and Co-Researchers - Vaccines
New Vaccines Study Results Reported from I.A. Menegolla et al - Vaccines
Beyond Darwin: Evolving new functions - Infectious Diseases
Data on Infectious Diseases Reported by Researchers at Institute for Systems Biology - Vaccines
Data on Vaccines Discussed by Researchers at University of Guelph - Vaccines
Data on Vaccines Reported by Researchers at Beth Israel Deaconess Medical Center - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
